Between the lines: a message of hope

J Child Neurol. 1989 Oct;4(4):272-3. doi: 10.1177/088307388900400404.

J Lewis ¹

Affiliations

Affiliation

1 Muscular Dystrophy Association, New York, NY 10019.

PMID: 2677114 DOI: 10.1177/088307388900400404

Products

Cat. No.

Product Name

Description

Target

Research Area
HY-100737

ML349

99.47%, APT2/LYPLA2 Inhibitor

Phospholipase

Cancer
HY-100737R

ML349 (Standard)

APT2/LYPLA2 Inhibitor

Reference Standards; Phospholipase

Cancer

MedChemExpress Magic Cece

MedChemExpress: Contact Us; About Us; Headquarters; Distributors; Statement on False Report; Careers

Customer Support: Technical Support; Service; Ordering Information; Easy Return; Shipping Rates & Policies; Intellectual Property Promise

Resources: Free Sample; Resources; Molarity Calculator; Dilution Calculator; Terms & Conditions; Reconstitution Calculator; Specific Activity Calculator; DNA/RNA sequence conversion tools

Subscribe to our E-newsletter

Name
Email *

	Sorry, but the email address you supplied was invalid.

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.

Copyright © 2013-2026 MedChemExpress. All Rights Reserved.: Site Map Privacy and Cookie Policy

Join with us